272 related articles for article (PubMed ID: 18426778)
1. L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice.
Peterson SJ; Drummond G; Kim DH; Li M; Kruger AL; Ikehara S; Abraham NG
J Lipid Res; 2008 Aug; 49(8):1658-69. PubMed ID: 18426778
[TBL] [Abstract][Full Text] [Related]
2. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.
Li M; Kim DH; Tsenovoy PL; Peterson SJ; Rezzani R; Rodella LF; Aronow WS; Ikehara S; Abraham NG
Diabetes; 2008 Jun; 57(6):1526-35. PubMed ID: 18375438
[TBL] [Abstract][Full Text] [Related]
3. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice.
Peterson SJ; Kim DH; Li M; Positano V; Vanella L; Rodella LF; Piccolomini F; Puri N; Gastaldelli A; Kusmic C; L'Abbate A; Abraham NG
J Lipid Res; 2009 Jul; 50(7):1293-304. PubMed ID: 19224872
[TBL] [Abstract][Full Text] [Related]
4. ApoA1: mimetic peptide reverses adipocyte dysfunction in vivo and in vitro via an increase in heme oxygenase (HO-1) and Wnt10b.
Vanella L; Li M; Kim D; Malfa G; Bellner L; Kawakami T; Abraham NG
Cell Cycle; 2012 Feb; 11(4):706-14. PubMed ID: 22306989
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice.
Vecoli C; Cao J; Neglia D; Inoue K; Sodhi K; Vanella L; Gabrielson KK; Bedja D; Paolocci N; L'abbate A; Abraham NG
J Cell Biochem; 2011 Sep; 112(9):2616-26. PubMed ID: 21598304
[TBL] [Abstract][Full Text] [Related]
6. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice.
Burgess A; Li M; Vanella L; Kim DH; Rezzani R; Rodella L; Sodhi K; Canestraro M; Martasek P; Peterson SJ; Kappas A; Abraham NG
Hypertension; 2010 Dec; 56(6):1124-30. PubMed ID: 21041703
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells.
Kim DH; Burgess AP; Li M; Tsenovoy PL; Addabbo F; McClung JA; Puri N; Abraham NG
J Pharmacol Exp Ther; 2008 Jun; 325(3):833-40. PubMed ID: 18334666
[TBL] [Abstract][Full Text] [Related]
8. ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice.
Marino JS; Peterson SJ; Li M; Vanella L; Sodhi K; Hill JW; Abraham NG
Nutr Diabetes; 2012 Mar; 2(3):e33. PubMed ID: 23169576
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.
McGrath KC; Li X; Twigg SM; Heather AK
PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125
[TBL] [Abstract][Full Text] [Related]
10. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats.
Nicolai A; Li M; Kim DH; Peterson SJ; Vanella L; Positano V; Gastaldelli A; Rezzani R; Rodella LF; Drummond G; Kusmic C; L'Abbate A; Kappas A; Abraham NG
Hypertension; 2009 Mar; 53(3):508-15. PubMed ID: 19171794
[TBL] [Abstract][Full Text] [Related]
11. Heme oxygenase (HO-1) rescue of adipocyte dysfunction in HO-2 deficient mice via recruitment of epoxyeicosatrienoic acids (EETs) and adiponectin.
Burgess AP; Vanella L; Bellner L; Gotlinger K; Falck JR; Abraham NG; Schwartzman ML; Kappas A
Cell Physiol Biochem; 2012; 29(1-2):99-110. PubMed ID: 22415079
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats.
Peterson SJ; Husney D; Kruger AL; Olszanecki R; Ricci F; Rodella LF; Stacchiotti A; Rezzani R; McClung JA; Aronow WS; Ikehara S; Abraham NG
J Pharmacol Exp Ther; 2007 Aug; 322(2):514-20. PubMed ID: 17488882
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow fat contributes to insulin sensitivity and adiponectin secretion in premenopausal women.
Ermetici F; Briganti S; Delnevo A; Cannaò P; Leo GD; Benedini S; Terruzzi I; Sardanelli F; Luzi L
Endocrine; 2018 Feb; 59(2):410-418. PubMed ID: 28624865
[TBL] [Abstract][Full Text] [Related]
14. Reduced adiposity in ob/ob mice following total body irradiation and bone marrow transplantation.
Ablamunits V; Weisberg SP; Lemieux JE; Combs TP; Klebanov S
Obesity (Silver Spring); 2007 Jun; 15(6):1419-29. PubMed ID: 17557979
[TBL] [Abstract][Full Text] [Related]
15. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls.
Nassis GP; Papantakou K; Skenderi K; Triandafillopoulou M; Kavouras SA; Yannakoulia M; Chrousos GP; Sidossis LS
Metabolism; 2005 Nov; 54(11):1472-9. PubMed ID: 16253636
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
Sherman CB; Peterson SJ; Frishman WH
Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
[TBL] [Abstract][Full Text] [Related]
17. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin-resistant type-2 diabetes.
Ndisang JF; Jadhav A
Diabetes Obes Metab; 2013 Nov; 15(11):1029-39. PubMed ID: 23731386
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin.
Abraham NG; Li M; Vanella L; Peterson SJ; Ikehara S; Asprinio D
J Autoimmun; 2008 May; 30(3):128-35. PubMed ID: 18243659
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.
Kubota N; Terauchi Y; Kubota T; Kumagai H; Itoh S; Satoh H; Yano W; Ogata H; Tokuyama K; Takamoto I; Mineyama T; Ishikawa M; Moroi M; Sugi K; Yamauchi T; Ueki K; Tobe K; Noda T; Nagai R; Kadowaki T
J Biol Chem; 2006 Mar; 281(13):8748-55. PubMed ID: 16431926
[TBL] [Abstract][Full Text] [Related]
20. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice.
Sodhi K; Inoue K; Gotlinger KH; Canestraro M; Vanella L; Kim DH; Manthati VL; Koduru SR; Falck JR; Schwartzman ML; Abraham NG
J Pharmacol Exp Ther; 2009 Dec; 331(3):906-16. PubMed ID: 19717790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
